Researchers developed 'sepsis sensors' with magnetic nanoparticles that detect bacterial pathogens within a short period of time and identify suitable candidates for antibiotic therapies.

Flexible electronic nanomembranes show promise for revolutionary organ-on-chip technologies, potentially reducing the need for animal testing in medical research.